Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Retained Earnings (2013 - 2026)

Xencor (XNCR) posted quarterly Retained Earnings of $27000.0 for Q1 2026, down 100.0% year-over-year from $1.4 billion in Q1 2025, and up 100.0% quarter-over-quarter from -$796.0 million in Q4 2025.

Analysis

Xencor (XNCR) Retained Earnings (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Retained Earnings for 14 consecutive years, with $27000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Retained Earnings fell 100.0% year-over-year to $27000.0; the TTM figure through Mar 2026 stood at $27000.0 (down 100.0% YoY), while the FY2025 annual figure was -$796.0 million, down 157.61% from the prior year.
  • Retained Earnings climbed to $27000.0 in Q1 2026 per XNCR's latest filing, from -$796.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $1.4 billion in Q1 2025 and bottomed at -$796.0 million in Q4 2025.
  • Historically, Retained Earnings has averaged $149.6 million across 5 years, with a median of -$652000.0 in 2024.
  • On a YoY basis, Retained Earnings climbed as much as 903516.23% in 2025 and fell as far as 120034.82% in 2025.
  • Xencor's Retained Earnings stood at -$338.3 million in 2022, then soared by 100.38% to $1.3 million in 2023, then surged by 106918.36% to $1.4 billion in 2024, then plunged by 157.61% to -$796.0 million in 2025, then surged by 100.0% to $27000.0 in 2026.
  • Business Quant data shows XNCR's Retained Earnings at $27000.0 in Q1 2026, -$796.0 million in Q4 2025, and $1.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Xencor 2.02 Bn 1.65 Bn - 1.45 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.45 Bn
Mar 31, 2026 1.44 Bn
Dec 31, 2025 1.43 Bn
Sep 30, 2025 1.41 Bn
Jun 30, 2025 1.40 Bn
Mar 31, 2025 1.39 Bn
Dec 31, 2024 1.38 Bn
Sep 30, 2024 1.36 Bn
Jun 30, 2024 1.16 Bn
Mar 31, 2024 1.14 Bn
Dec 31, 2023 1.13 Bn
Sep 30, 2023 1.11 Bn
Jun 30, 2023 1.10 Bn
Mar 31, 2023 1.09 Bn
Dec 31, 2022 1.07 Bn
Sep 30, 2022 1.06 Bn
Jun 30, 2022 1.04 Bn
Mar 31, 2022 1.03 Bn
Dec 31, 2021 1.02 Bn
Sep 30, 2021 974.51 Mn